Cargando…
Association of Aberrant Promoter Methylation Changes in the Suppressor of Cytokine Signaling 3 (SOCS3) Gene with Susceptibility to Crohn's Disease
BACKGROUND: Growing evidence supports that changes in the methylation state of Inflammatory Bowel Disease (IBD)-associated genes could significantly alter levels of gene expression, potentially contributing to disease onset and progression. We supposed that alterations in DNA methylation status at p...
Autores principales: | Sanati, Golshid, Jafari, Davood, Noruzinia, Mehrdad, Ebrahimi Daryani, Naser, Ahmadvand, Mohammad, Teimourian, Shahram, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077662/ https://www.ncbi.nlm.nih.gov/pubmed/35633985 http://dx.doi.org/10.18502/ajmb.v14i2.8887 |
Ejemplares similares
-
Association between Promotor hypomethylation of TFF1 and Crohn’s Disease
por: Hemmati, Sara, et al.
Publicado: (2022) -
Tissue levels of suppressor of cytokine signaling-3 (SOCS-3) in mycosis fungoides
por: Nada, Hanan R., et al.
Publicado: (2022) -
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms
por: Fukushima, N, et al.
Publicado: (2003) -
Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk
por: Hamilton, Kathryn E, et al.
Publicado: (2010) -
Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression
por: Williams, Jamie J. L., et al.
Publicado: (2014)